Vaxart, Inc. (VXRT)
0.673
+0.02
(+3.49%)
USD |
OTCM |
May 15, 10:19
Vaxart EPS Diluted (Quarterly) : 0.0214 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| Capricor Therapeutics, Inc. | -0.591 |
| Allogene Therapeutics, Inc. | -0.1773 |
| Agenus, Inc. | 1.023 |
| Curis, Inc. | -1.250 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.179M |
| Revenue (Quarterly) | 39.23M |
| Total Expenses (Quarterly) | 34.05M |
| Enterprise Value | 108.54M |
| Gross Profit Margin (Quarterly) | 97.13% |
| Profit Margin (Quarterly) | 13.20% |
| Earnings Yield | 22.15% |
| Operating Earnings Yield | 24.14% |
| Normalized Earnings Yield | 22.15 |